167 related articles for article (PubMed ID: 17211228)
1. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans.
Calò LA; Pessina AC
J Hypertens; 2007 Feb; 25(2):259-64. PubMed ID: 17211228
[TBL] [Abstract][Full Text] [Related]
2. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights.
Jin L; Burnett AL
Clin Sci (Lond); 2006 Feb; 110(2):153-65. PubMed ID: 16411892
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
4. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells.
Nakakuki T; Ito M; Iwasaki H; Kureishi Y; Okamoto R; Moriki N; Kongo M; Kato S; Yamada N; Isaka N; Nakano T
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2088-93. PubMed ID: 16123329
[TBL] [Abstract][Full Text] [Related]
5. The RhoA/Rho kinase pathway in the myocardium.
Peters SL; Michel MC
Cardiovasc Res; 2007 Jul; 75(1):3-4. PubMed ID: 17499228
[No Abstract] [Full Text] [Related]
6. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
7. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
[TBL] [Abstract][Full Text] [Related]
8. [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling].
Jalil J; Lavandero S; Chiong M; Ocaranza MP
Rev Esp Cardiol; 2005 Aug; 58(8):951-61. PubMed ID: 16053829
[TBL] [Abstract][Full Text] [Related]
9. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
[TBL] [Abstract][Full Text] [Related]
10. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle.
Somlyo AP; Somlyo AV
J Muscle Res Cell Motil; 2004; 25(8):613-5. PubMed ID: 15750846
[No Abstract] [Full Text] [Related]
12. Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.
Hu E; Lee D
Curr Opin Investig Drugs; 2003 Sep; 4(9):1065-75. PubMed ID: 14582450
[TBL] [Abstract][Full Text] [Related]
13. Microtubule depolymerization facilitates contraction of vascular smooth muscle via increased activation of RhoA/Rho-kinase.
Chitaley K; Webb RC
Med Hypotheses; 2001 Mar; 56(3):381-5. PubMed ID: 11359365
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase.
Bolz SS; Vogel L; Sollinger D; Derwand R; Boer C; Pitson SM; Spiegel S; Pohl U
Circulation; 2003 Jul; 108(3):342-7. PubMed ID: 12847068
[TBL] [Abstract][Full Text] [Related]
15. Rho-kinase is an important therapeutic target in cardiovascular medicine.
Shimokawa H; Takeshita A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
[TBL] [Abstract][Full Text] [Related]
16. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways.
Zeidan A; Paylor B; Steinhoff KJ; Javadov S; Rajapurohitam V; Chakrabarti S; Karmazyn M
J Pharmacol Exp Ther; 2007 Sep; 322(3):1110-6. PubMed ID: 17562852
[TBL] [Abstract][Full Text] [Related]
17. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
Budzyn K; Marley PD; Sobey CG
Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
[TBL] [Abstract][Full Text] [Related]
18. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation.
Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M
J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559
[TBL] [Abstract][Full Text] [Related]
19. Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells.
Sugimoto M; Nakayama M; Goto TM; Amano M; Komori K; Kaibuchi K
Biochem Biophys Res Commun; 2007 Sep; 361(2):462-7. PubMed ID: 17651694
[TBL] [Abstract][Full Text] [Related]
20. Phenylalanine activates the mitochondria-mediated apoptosis through the RhoA/Rho-associated kinase pathway in cortical neurons.
Zhang Y; Gu X; Yuan X
Eur J Neurosci; 2007 Mar; 25(5):1341-8. PubMed ID: 17425560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
